Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Sep;75(Suppl 3):iii47–iii52. doi: 10.1136/jnnp.2004.045740

PITUITARY DISEASE: PRESENTATION, DIAGNOSIS, AND MANAGEMENT

A Levy
PMCID: PMC1765669  PMID: 15316045

Full Text

The Full Text of this article is available as a PDF (111.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellastella Antonio, Bizzarro Antonio, Coronella Concetta, Bellastella Giuseppe, Sinisi Antonio Agostino, De Bellis Annamaria. Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol. 2003 Nov;149(5):363–376. doi: 10.1530/eje.0.1490363. [DOI] [PubMed] [Google Scholar]
  2. Biller Beverly M. K., Samuels Mary H., Zagar Anthony, Cook David M., Arafah Baha M., Bonert Vivien, Stavrou Stavros, Kleinberg David L., Chipman John J., Hartman Mark L. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002 May;87(5):2067–2079. doi: 10.1210/jcem.87.5.8509. [DOI] [PubMed] [Google Scholar]
  3. Invitti C., Pecori Giraldi F., de Martin M., Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab. 1999 Feb;84(2):440–448. doi: 10.1210/jcem.84.2.5465. [DOI] [PubMed] [Google Scholar]
  4. Levy Andy, Lightman Stafford. Molecular defects in the pathogenesis of pituitary tumours. Front Neuroendocrinol. 2003 Apr;24(2):94–127. doi: 10.1016/s0091-3022(03)00012-8. [DOI] [PubMed] [Google Scholar]
  5. Marcou Y., Plowman P. N. Stereotactic radiosurgery for pituitary adenomas. Trends Endocrinol Metab. 2000 May-Jun;11(4):132–137. doi: 10.1016/s1043-2760(00)00242-3. [DOI] [PubMed] [Google Scholar]
  6. Melmed Shlomo, Vance Mary Lee, Barkan Ariel L., Bengtsson Bengt-Ake, Kleinberg David, Klibanski Anne, Trainer Peter J. Current status and future opportunities for controlling acromegaly. Pituitary. 2002;5(3):185–196. doi: 10.1023/a:1023369317275. [DOI] [PubMed] [Google Scholar]
  7. Orme S. M., McNally R. J., Cartwright R. A., Belchetz P. E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab. 1998 Aug;83(8):2730–2734. doi: 10.1210/jcem.83.8.5007. [DOI] [PubMed] [Google Scholar]
  8. Racine Michael S., Barkan Ariel L. Medical management of growth hormone-secreting pituitary adenomas. Pituitary. 2002;5(2):67–76. doi: 10.1023/a:1022356313153. [DOI] [PubMed] [Google Scholar]
  9. Stewart Paul M. Pegvisomant: an advance in clinical efficacy in acromegaly. Eur J Endocrinol. 2003 Apr;148 (Suppl 2):S27–S32. doi: 10.1530/eje.0.148s027. [DOI] [PubMed] [Google Scholar]
  10. Yanovski J. A., Cutler G. B., Jr, Chrousos G. P., Nieman L. K. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 1993 May 5;269(17):2232–2238. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES